MVM Partners LLP Closes MVM V

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BOSTON & LONDON–(BUSINESS WIRE)–MVM Partners today announced the closing of a $325 million healthcare fund, MVM V.

MVM has been investing in high growth healthcare businesses since 1997 and this latest fund, MVM V, will continue this broad, global, investment remit with investments in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, and digital health in both private deals and quoted companies. Typical projected investment in each company is $20 to $40 million, but with capacity for larger investments.

In aggregate, MVM has raised investment vehicles totaling over $1 billion which are managed from offices in Boston and London. For more information visit www.mvm.com.

This press release, together with any information or documents accompanying it, is issued by MVM Partners LLP, which is authorised and regulated in the UK by the Financial Conduct Authority.

This document does not constitute an offer or invitation to subscribe or purchase limited partnership interests. Any investment in MVM V LP will be made solely on the basis of the private placement memorandum issued in connection therewith and the limited partnership agreement and associated documentation.

Contacts

MVM Partners LLP
Dr Stephen Reeders

sr@mvm.com

Dr Eric Bednarski

eb@mvm.com

Mr Thomas Casdagli

tc@mvm.com

Staff

Recent Posts

hūmānus and ARSPHR Launch Groundbreaking Rohingya Atrocities Archive, Continuing Mohibullah’s Sacrificial Fight for Truth and Justice

"If I die, it's okay. I will give my life for my community." Mohibullah LONDON, July…

49 minutes ago

Seegene unveils the world’s first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025

Fully Unmanned— CURECA™, the 100% Automated Diagnostic System Defining the Future Gold Standard, Debuts in Chicago,…

49 minutes ago

Nutex Health Responds to Short Seller Report

HOUSTON, July 23, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:…

7 hours ago

Happy Docs Make Happy Patients

AI technology boosts face-to-face time with patients, earns Mercy national recognition for physician satisfaction ST.…

7 hours ago

Waystar to Acquire Iodine Software, Accelerating the AI-Powered Transformation of Healthcare Payments

Extends Waystar's AI leadership into clinical intelligence software, unlocking greater value for clients and shareholders Highly…

13 hours ago

HAMILTON BEACH BRANDS HOLDING COMPANY ANNOUNCES DATES OF ITS 2025 SECOND QUARTER EARNINGS RELEASE AND CONFERENCE CALL

GLEN ALLEN, Va., July 23, 2025 /PRNewswire/ -- Hamilton Beach Brands Holding Company (NYSE: HBB)…

13 hours ago